The present report shows that the following statement is correct: 'Uncomplicated peptic ulcer is best treated with a strongly acting histamine antagonist given once daily with dinner for 4 weeks and by abstention from smoking'
This article reviews the current status of H2 receptor antagonists, omeprazole, sucralfate and misop...
One major cause of peptic ulceration is the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Th...
The cure rate for endoscopic therapy was determined in 61 patients with a gastroduodenal ulcer who r...
The present report shows that the following statement is correct: 'Uncomplicated peptic ulcer is bes...
The first histamine H2 receptor antagonists (H2RAs) were developed in the early 1970s. They played a...
ALTHOUGH there has been a definite decrease in the in-cidence of peptic ulcer during the past 10 to ...
The treatment of peptic ulcer disease has undergone a revolution in the past decade. This revolution...
An evaluation of a recent study by MacLaren R, Reynolds PM, Allen RR et al: Histamine-2 receptor ant...
This paper reviews the remarkable impact of H2-receptor antagonists on duodenal ulcer management. Th...
Background: Proton-pump inhibitors (PPI) and histamine-2 receptor antagonists (H2RA) are common acid...
BACKGROUND: Histamine2 (H2)-receptor antagonists and antacids have been the mainstay pharmacologic a...
In the last few years, several drugs have been proposed for the healing of peptic ulcers H2 receptor...
Goals of work: Inoperable bowel obstructions are not uncommon in advanced cancer and are associated ...
Therapy of gastric and duodenal ulcers has achieved a striking progress of the appearance of muscari...
The histamine H2-receptor antagonists, cimetidine, ranitidine, famotidine and nizatidine are effecti...
This article reviews the current status of H2 receptor antagonists, omeprazole, sucralfate and misop...
One major cause of peptic ulceration is the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Th...
The cure rate for endoscopic therapy was determined in 61 patients with a gastroduodenal ulcer who r...
The present report shows that the following statement is correct: 'Uncomplicated peptic ulcer is bes...
The first histamine H2 receptor antagonists (H2RAs) were developed in the early 1970s. They played a...
ALTHOUGH there has been a definite decrease in the in-cidence of peptic ulcer during the past 10 to ...
The treatment of peptic ulcer disease has undergone a revolution in the past decade. This revolution...
An evaluation of a recent study by MacLaren R, Reynolds PM, Allen RR et al: Histamine-2 receptor ant...
This paper reviews the remarkable impact of H2-receptor antagonists on duodenal ulcer management. Th...
Background: Proton-pump inhibitors (PPI) and histamine-2 receptor antagonists (H2RA) are common acid...
BACKGROUND: Histamine2 (H2)-receptor antagonists and antacids have been the mainstay pharmacologic a...
In the last few years, several drugs have been proposed for the healing of peptic ulcers H2 receptor...
Goals of work: Inoperable bowel obstructions are not uncommon in advanced cancer and are associated ...
Therapy of gastric and duodenal ulcers has achieved a striking progress of the appearance of muscari...
The histamine H2-receptor antagonists, cimetidine, ranitidine, famotidine and nizatidine are effecti...
This article reviews the current status of H2 receptor antagonists, omeprazole, sucralfate and misop...
One major cause of peptic ulceration is the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Th...
The cure rate for endoscopic therapy was determined in 61 patients with a gastroduodenal ulcer who r...